|
Lurasidone impurity 1
|
魯拉西酮雜質(zhì)1
|
223586-82-1
|
|
Linagliptin Impurity 44
|
利格列汀雜質(zhì)44
|
|
|
Irinotecan hydrolyzes ring-opening Impurity
|
伊立替康水解開環(huán)雜質(zhì)
|
1329502-92-2
|
|
Lacosamide EP Impurity A
|
拉科酰胺EP雜質(zhì)A
|
|
|
Lacosamide EP Impurity F
|
拉科酰胺EP雜質(zhì)F
|
|
|
Linezolid Impurity 24
|
利奈唑胺雜質(zhì)24
|
|
|
Linezolid Impurity 33
|
利奈唑胺雜質(zhì)33
|
|
|
Lenalidomide Impurity Z2
|
來那度胺雜質(zhì)Z2
|
|
|
Lenvatinib Impurity 18
|
樂伐替尼雜質(zhì)18
|
|
|
Linezolid Impurity 21
|
利奈唑胺雜質(zhì)21
|
2524-67-6
|
|
Metoprolol Impurity B
|
美托洛爾雜質(zhì)B
|
56718-71-9
|
|
Nitrendipine propyl ester
|
樂卡地平雜質(zhì)7
|
225785-54-6
|
|
Linezolid Impurity 32
|
利奈唑胺雜質(zhì)32
|
|
|
Lenvatinib Impurity 19
|
樂伐替尼雜質(zhì)16
|
417724-81-3
|
|
Lenvatinib Impurity 4
|
樂伐替尼雜質(zhì)4
|
417717-04-5
|
|
Linagliptin Impurity 41
|
利格列汀雜質(zhì)41
|
|
|
|
|
|
|
Linezolid Impurity 26
|
利奈唑胺雜質(zhì)26
|
|
|
Lenvatinib Impurity 10
|
樂伐替尼雜質(zhì)10
|
|
|
Irinotecan pyridine N oxide
|
伊立替康吡啶N氧化物
|
|
|
LCZ696（valsartan + sacubitril） impurity 34
|
沙庫巴曲纈沙坦雜質(zhì)34
|
|
|
Lenvatinib Impurity 27
|
樂伐替尼雜質(zhì)27
|
|
|
Linezolid Impurity 22
|
利奈唑胺雜質(zhì)22
|
93246-53-8
|
|
Irinotecan EP Impurity G
|
伊立替康EP雜質(zhì)G
|
947687-01-6
|
|
|
|
|
|
Lacosamide EP Impurity E
|
拉科酰胺EP雜質(zhì)E
|
|
|
Lacosamide EP Impurity J
|
拉科酰胺EP雜質(zhì)J
|
|
|
Irinotecan Impurity 14 HCl
|
鹽酸伊立替康雜質(zhì)14
|
53877-76-2
|
|
Lurasidone impurity 3
|
魯拉西酮雜質(zhì)3
|
|
|
Irinotecan Impurity 17 HCl
|
鹽酸伊立替康雜質(zhì)17
|
1332610-75-9
|
|
LCZ696（valsartan + sacubitril） impurity 31
|
沙庫巴曲纈沙坦雜質(zhì)31
|
|
|
Lenvatinib Impurity 24
|
樂伐替尼雜質(zhì)24
|
|
|
Lenvatinib Impurity 30
|
樂伐替尼雜質(zhì)30
|
|
|
Lurasidone (hydrochloride)
|
魯拉西酮雜質(zhì)4
|
367514-88-3
|
|
(R)-N-benzyl-3-methoxy-2-(N-methylacetamido)propanamide
|
拉科酰胺EP雜質(zhì)C
|
1318777-56-8
|
|
Isoniazid Impurity 7
|
托匹司他雜質(zhì)26共50種雜質(zhì)
|
38634-05-8
|
|
Linagliptin Impurity 45
|
利格列汀雜質(zhì)45
|
|
|
Lacosamide EP Impurity B
|
拉科酰胺EP雜質(zhì)B
|
|
|
Lacosamide EP Impurity G
|
拉科酰胺EP雜質(zhì)G
|
|
|
Linezolid Impurity 25
|
利奈唑胺雜質(zhì)25
|
|
|
Linezolid Impurity 34
|
利奈唑胺雜質(zhì)34
|
|
|
Lenalidomide Impurity Z3
|
來那度胺雜質(zhì)Z3
|
|
|
Lenvatinib Impurity 21
|
樂伐替尼雜質(zhì)21
|
|
|
Linezolid Impurity 12
|
利奈唑胺雜質(zhì)12
|
|
|
1-(ethylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol
|
美托洛爾雜質(zhì)A
|
109632-08-8
|
|
N,N-bis(((S)-3-(3-fluoro-4-morpholinophenyl)-
|
利奈唑胺二聚體雜質(zhì)
|
908143-04-4
|
|
Isoleucine Valsartan
|
纈沙坦雜質(zhì)全套
|
137862-78-3
|
|
Lenvatinib Impurity 5
|
樂伐替尼雜質(zhì)5
|
417717-20-5
|
|
Linagliptin Impurity 42
|
利格列汀雜質(zhì)42
|
|
|
|
|
|
|
Linezolid Impurity 30
|
利奈唑胺雜質(zhì)30
|
|
|
Ivabradine Impurity 36
|
伊伐布雷定雜質(zhì)36
|
|
|
LCZ696（valsartan + sacubitril） impurity 35
|
沙庫巴曲纈沙坦雜質(zhì)35
|
|
|
Lenvatinib Impurity 15
|
樂伐替尼雜質(zhì)15
|
|
|
Irinotecan EP Impurity F
|
伊立替康EP雜質(zhì)F
|
78287-27-1
|
|
Irinotecan Hydroxyl Acid 19
|
鹽酸伊立替康雜質(zhì)19
|
110351-92-3
|
|
Levosimendan
|
|
141505-33-1
|
|
|
|
|
|
Vitamin B6 Impurity 87
|
|
1797983-23-3
|
|
Lacosamide EP Impurity K
|
拉科酰胺EP雜質(zhì)K
|
|
|
Irinotecan Impurity 20 HCl
|
鹽酸伊立替康雜質(zhì)20
|
870527-52-9
|
|
LCZ696（valsartan + sacubitril） impurity 32
|
沙庫巴曲纈沙坦雜質(zhì)32
|
|
|
Lenvatinib Impurity 25
|
樂伐替尼雜質(zhì)25
|
|
|
Leosimendan azide Impurity
|
左西孟旦疊氮雜質(zhì)
|
|
|
Irinotecan Impurity 15 HCl
|
鹽酸伊立替康雜質(zhì)15
|
116269-53-5
|
|
Lacosamide EP Impurity H
|
拉科酰胺EP雜質(zhì)H
|
|
|
Linezolid Impurity 35
|
利奈唑胺雜質(zhì)35
|
|
|
Linagliptin Impurity 38
|
利格列汀雜質(zhì)38
|
3037659-49-4
|
|
Lenalidomide Impurity Z4
|
來那度胺雜質(zhì)Z4
|
|
|
Lenvatinib Impurity 22
|
樂伐替尼雜質(zhì)22
|
|
|
Irinotecan Impurity 18 HCl
|
鹽酸伊立替康雜質(zhì)18
|
25387-67-1
|
|
Linagliptin Impurity 43
|
利格列汀雜質(zhì)43
|
|
|
Irinotecan ring opening impurity
|
伊立替康開環(huán)雜質(zhì)
|
176515-52-9
|
|
Linezolid Impurity 23
|
利奈唑胺雜質(zhì)23
|
|
|
Linezolid Impurity 31
|
利奈唑胺雜質(zhì)31
|
|
|
LCZ696（valsartan + sacubitril） impurity 36
|
沙庫巴曲纈沙坦雜質(zhì)36
|
|
|
Lenvatinib Impurity 17
|
樂伐替尼雜質(zhì)17
|
|
|
Itraconazole iMpurity 1
|
伊曲康唑雜質(zhì) 1
|
|
|
Lercanidipin dimethyl Impurity
|
樂卡地平二甲酯雜質(zhì)
|
77888-05-2
|
|
Lercanidipin Impurity C HCl
|
樂卡地平雜質(zhì)C鹽酸鹽
|
1797124-83-4
|
|
Linagliptin Impurity 40
|
利格列汀雜質(zhì)40
|
|
|
|
|
|
|
Phthalamic Acid
|
魯拉西酮雜質(zhì)2
|
1574569-32-6
|
|
Irinotecan piperidine N oxide
|
伊立替康哌啶N氧化物
|
|
|
LCZ696（valsartan + sacubitril） impurity 33
|
沙庫巴曲纈沙坦雜質(zhì)33
|
|
|
Lenvatinib Impurity 26
|
樂伐替尼雜質(zhì)26
|
|
|
Leosimendan dimer Impurity
|
左西孟旦二聚體雜質(zhì)
|
|
|
Mesalazine Impurity I
|
|
3147-53-3
|
|
Irinotecan quinone lactone impurity
|
伊立替康五元內(nèi)酯雜質(zhì)
|
143490-53-3
|
|
Linezolid Impurity 29
|
利奈唑胺雜質(zhì)29
|
|
|
Lincomycin hydrochloride impurity A
|
鹽酸林可霉素雜質(zhì)A
|
|
|
Lercanidipin Impurity J
|
樂卡地平雜質(zhì)J
|
210579-71-8
|
|
2-amino-N-benzyl-3-methoxypropanamide
|
拉科酰胺EP雜質(zhì)D
|
|
|
Lacosamide EP Impurity I
|
拉科酰胺EP雜質(zhì)I
|
|
|
Linezolid Impurity 36
|
利奈唑胺雜質(zhì)36
|
|
|
Linagliptin Impurity 39
|
利格列汀雜質(zhì)39
|
|
|
Irinotecan Furan ring impurity
|
伊立替康呋喃環(huán)雜質(zhì)
|
143490-54-4
|
|
Lenvatinib Impurity 14
|
樂伐替尼雜質(zhì)14
|
|
|
Lenvatinib Impurity 23
|
樂伐替尼雜質(zhì)23
|
|
|
Lenvatinib Impurity 28
|
樂伐替尼雜質(zhì)28
|
|